Peroxiredoxin-2 and peroxiredoxin-4 in cluster 2, which were up-regulated in many cancers [38-40], showed a significant decrease upon OT-treatment for 12 hr but increased to almost basal level after OT treatment for 48 hr. The gene discussed is PRDX4; the disease is cancer.